Phase i study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: Blockade of the immune checkpoint CD200
- Daruka Mahadevan
- , Mark C. Lanasa
- , Charles Farber
- , Manjari Pandey
- , Maria Whelden
- , Susan J. Faas
- , Terrie Ulery
- , Anjli Kukreja
- , Lan Li
- , Camille L. Bedrosian
- , Xiaoping Zhang
- , Leonard T. Heffner
Producción científica: Article › revisión exhaustiva
76
!!Link opens in a new tab
Citas
(Scopus)